BACKGROUND: The water-perfusable tissue index (PTI) is assumed to differentiate viable myocardium from scar tissue, but histological comparisons in humans are lacking. The present study compares PTI with delayed contrast-enhanced magnetic resonance imaging (DCE-MRI), a validated marker of fibrotic tissue, in patients with ischemic left ventricular (LV) dysfunction. In addition, the optimal PTI threshold for detection of myocardial viability was defined when DCE-MRI was taken as a reference. MATERIALS: Twenty patients with ischemic LV dysfunction were studied with positron emission tomography, using oxygen-15-labeled water and carbon monoxide as tracers, and DCE-MRI. RESULTS: Of the 200 analyzed segments, 112 demonstrated DCE and were subsequently divided in three subgroups according to the severity of enhancement. PTI was 1.04 +/- 0.21 in control segments and gradually decreased with increasing extent of DCE to 0.77 +/- 0.31 for segments with transmural enhancement (p < 0.001). However, PTI progressively underestimated infarct size with increasing quantities of scar tissue (r = 0.61, p < 0.01). A PTI cutoff value of 0.89 yielded the best diagnostic accuracy for detection of myocardial viability with sensitivity and specificity values of 75 and 77%, respectively. CONCLUSIONS: PTI is inversely related to the extent of scar tissue estimated by DCE-MRI in patients with chronic ischemic heart disease and LV dysfunction. However, with increasing quantities of scar tissue, PTI overestimates the extent of residual viable tissue. A PTI threshold of 0.89 yields the best diagnostic accuracy for viability detection.
BACKGROUND: The water-perfusable tissue index (PTI) is assumed to differentiate viable myocardium from scar tissue, but histological comparisons in humans are lacking. The present study compares PTI with delayed contrast-enhanced magnetic resonance imaging (DCE-MRI), a validated marker of fibrotic tissue, in patients with ischemic left ventricular (LV) dysfunction. In addition, the optimal PTI threshold for detection of myocardial viability was defined when DCE-MRI was taken as a reference. MATERIALS: Twenty patients with ischemic LV dysfunction were studied with positron emission tomography, using oxygen-15-labeled water and carbon monoxide as tracers, and DCE-MRI. RESULTS: Of the 200 analyzed segments, 112 demonstrated DCE and were subsequently divided in three subgroups according to the severity of enhancement. PTI was 1.04 +/- 0.21 in control segments and gradually decreased with increasing extent of DCE to 0.77 +/- 0.31 for segments with transmural enhancement (p < 0.001). However, PTI progressively underestimated infarct size with increasing quantities of scar tissue (r = 0.61, p < 0.01). A PTI cutoff value of 0.89 yielded the best diagnostic accuracy for detection of myocardial viability with sensitivity and specificity values of 75 and 77%, respectively. CONCLUSIONS: PTI is inversely related to the extent of scar tissue estimated by DCE-MRI in patients with chronic ischemic heart disease and LV dysfunction. However, with increasing quantities of scar tissue, PTI overestimates the extent of residual viable tissue. A PTI threshold of 0.89 yields the best diagnostic accuracy for viability detection.
Authors: R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: Harald P Kühl; Aernout M Beek; Arno P van der Weerdt; Mark B M Hofman; Cees A Visser; Adriaan A Lammertsma; Nicole Heussen; Frans C Visser; Albert C van Rossum Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Jeroen J Bax; Farzin Fath-Ordoubadi; Eric Boersma; William Wijns; Paolo G Camici Journal: Eur J Nucl Med Mol Imaging Date: 2002-04-10 Impact factor: 9.236
Authors: Joseph B Selvanayagam; Attila Kardos; Jane M Francis; Frank Wiesmann; Steffen E Petersen; David P Taggart; Stefan Neubauer Journal: Circulation Date: 2004-09-07 Impact factor: 29.690
Authors: Hassan Abdel-Aty; Anja Zagrosek; Jeanette Schulz-Menger; Andrew J Taylor; Daniel Messroghli; Andreas Kumar; Michael Gross; Rainer Dietz; Matthias G Friedrich Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: R M Judd; C H Lugo-Olivieri; M Arai; T Kondo; P Croisille; J A Lima; V Mohan; L C Becker; E A Zerhouni Journal: Circulation Date: 1995-10-01 Impact factor: 29.690
Authors: Paul Knaapen; Ronald Boellaard; Marco J W Götte; Pieter A Dijkmans; Linda M C van Campen; Carel C de Cock; Gert Luurtsema; Cees A Visser; Adriaan A Lammertsma; Frans C Visser Journal: J Nucl Med Date: 2004-08 Impact factor: 10.057
Authors: Stefan de Haan; Mischa T Rijnierse; Hendrik J Harms; Hein J Verberne; Adriaan A Lammertsma; Marc C Huisman; Albert D Windhorst; Albert C van Rossum; Cornelis P Allaart; Paul Knaapen Journal: J Nucl Cardiol Date: 2015-11-09 Impact factor: 5.952
Authors: Andrew J Buckler; Tiffany Ting Liu; Erica Savig; Baris E Suzek; M Ouellette; J Danagoulian; G Wernsing; Daniel L Rubin; David Paik Journal: J Digit Imaging Date: 2013-08 Impact factor: 4.056
Authors: Stefan de Haan; Hendrik J Harms; Mark Lubberink; Cornelis P Allaart; Ibrahim Danad; Weena J Y Chen; Michaela Diamant; Albert C van Rossum; Hidehiro Iida; Adriaan A Lammertsma; Paul Knaapen Journal: Eur J Nucl Med Mol Imaging Date: 2012-05-11 Impact factor: 9.236